Main Menu

Clinical Pharmacodynamics Biomarker Group

Professor Banerji's team focuses on the development and validation of quantifiable and reproducible robust pharmacodynamic biomarkers in normal and tumour tissue that can be used in first-in-human studies.

Team leader

Professor Udai Banerji

Professor Udai Banerji

Professor Udai Banerji champions multidisciplinary working at the interface between early phase clinical trials, drug discovery and translational research related to drug resistance. He is Deputy Director of the Drug Development Unit at The ICR and Royal Marsden, and as a key member of the Cancer Research UK Cancer Therapeutics Unit, also heads the Clinical Pharmacodynamics Biomarker Group and the Clinical Pharmacology-Adaptive Therapy Group.

ORCID 0000-0003-1503-3123

Team members

Shaun Decordova

Higher Scientific Officer

Dr Sara Diaz-Sanchez

Higher Scientific Officer

Jason Malia

Scientific Officer

​Dr Karen Swales

Senior Scientific Officer

Matthew Tall

Higher Scientific Officer